Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)

China · Delayed Price · Currency is CNY

20.07

+0.79 (4.10%)

Sep 30, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Sales of active pharmaceutical ingredients and Intermediates	1.47B	1.14B	-					-	-
Sale of Drug Product	184.40M	220.02M	-					-	-
Trading of active pharmaceutical ingredients and intermediates	36.00M	111.39M	-					-	-
Others	8.73M	3.67M	-					-	-
Raw Materials and Intermediates	-	-	-					447.50M	434.25M
Trading	-	-	-					127.61M	109.28M
Total	1.70B	1.48B	-					575.11M	543.53M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	345.96M	330.45M	168.05M					-	-
Overseas	1.35B	1.15B	1.09B					-	-
Asian Region	-	-	-					168.71M	154.58M
South America	-	-	-					133.58M	97.80M
North America	-	-	-					30.25M	43.70M
African Region	-	-	-					595.50K	733.30K
European Region	-	-	-					241.97M	246.72M
Total	1.70B	1.48B	1.26B					575.11M	543.53M